Conestoga Capital Advisors LLC decreased its holdings in shares of Danaher Co. (NYSE:DHR) by 8.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,855 shares of the conglomerate’s stock after selling 180 shares during the quarter. Conestoga Capital Advisors LLC’s holdings in Danaher were worth $268,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. Next Capital Management LLC bought a new stake in Danaher during the 2nd quarter valued at approximately $31,000. Litman Gregory Asset Management LLC bought a new stake in Danaher during the 2nd quarter valued at approximately $33,000. Altshuler Shaham Ltd boosted its stake in Danaher by 59.3% during the 2nd quarter. Altshuler Shaham Ltd now owns 239 shares of the conglomerate’s stock valued at $34,000 after purchasing an additional 89 shares during the period. Pinnacle Bank boosted its stake in Danaher by 52.3% during the 3rd quarter. Pinnacle Bank now owns 262 shares of the conglomerate’s stock valued at $38,000 after purchasing an additional 90 shares during the period. Finally, MRA Associates USA LLC bought a new stake in Danaher during the 2nd quarter valued at approximately $40,000. Hedge funds and other institutional investors own 78.47% of the company’s stock.
In related news, Chairman Mitchell P. Rales bought 2,500 shares of the company’s stock in a transaction dated Friday, August 23rd. The stock was acquired at an average cost of $139.52 per share, with a total value of $348,800.00. Following the acquisition, the chairman now owns 3,030,453 shares in the company, valued at approximately $422,808,802.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 11.40% of the company’s stock.
Danaher stock opened at $136.21 on Tuesday. The business has a 50 day moving average price of $140.27 and a two-hundred day moving average price of $137.91. The company has a quick ratio of 3.09, a current ratio of 3.43 and a debt-to-equity ratio of 0.52. The stock has a market cap of $97.59 billion, a price-to-earnings ratio of 28.91, a price-to-earnings-growth ratio of 2.28 and a beta of 0.94. Danaher Co. has a 12 month low of $94.59 and a 12 month high of $147.33.
Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 24th. The conglomerate reported $1.16 EPS for the quarter, beating the consensus estimate of $1.15 by $0.01. The firm had revenue of $5.04 billion during the quarter, compared to analysts’ expectations of $5.02 billion. Danaher had a return on equity of 11.42% and a net margin of 12.13%. The company’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.10 EPS. On average, analysts expect that Danaher Co. will post 4.76 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.17 dividend. The ex-dividend date of this dividend was Thursday, September 26th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.50%. Danaher’s payout ratio is presently 15.04%.
Several brokerages recently weighed in on DHR. Needham & Company LLC decreased their target price on Danaher from $155.00 to $152.00 and set a “buy” rating for the company in a research note on Monday. ValuEngine cut Danaher from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Royal Bank of Canada set a $134.00 price target on Danaher and gave the company a “hold” rating in a report on Friday, July 19th. Argus upped their price target on Danaher to $165.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Finally, Piper Jaffray Companies upped their price target on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a report on Thursday, July 18th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $145.86.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Further Reading: How to start trading in the forex market?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.